Analysts Set IQVIA Holdings Inc. (NYSE:IQV) PT at $255.82

IQVIA Holdings Inc. (NYSE:IQV - Get Free Report) has been given an average recommendation of "Moderate Buy" by the twenty-one brokerages that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $255.82.

IQV has been the topic of a number of recent analyst reports. Robert W. Baird dropped their price target on shares of IQVIA from $213.00 to $212.00 and set a "neutral" rating on the stock in a research report on Wednesday, December 11th. Barclays cut their target price on IQVIA from $260.00 to $255.00 and set an "overweight" rating on the stock in a research note on Friday, November 1st. StockNews.com downgraded IQVIA from a "buy" rating to a "hold" rating in a research report on Thursday, November 28th. Royal Bank of Canada reissued an "outperform" rating and issued a $270.00 price objective on shares of IQVIA in a research report on Wednesday, December 11th. Finally, Truist Financial decreased their target price on IQVIA from $265.00 to $261.00 and set a "buy" rating for the company in a research report on Thursday, December 12th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of IQV. Capital Performance Advisors LLP purchased a new stake in shares of IQVIA during the 3rd quarter valued at $27,000. Park Place Capital Corp bought a new position in shares of IQVIA during the 3rd quarter valued at about $28,000. Itau Unibanco Holding S.A. purchased a new stake in IQVIA during the second quarter valued at about $29,000. International Assets Investment Management LLC purchased a new position in shares of IQVIA in the second quarter worth about $32,000. Finally, Avior Wealth Management LLC lifted its stake in shares of IQVIA by 117.6% in the 3rd quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company's stock valued at $38,000 after acquiring an additional 87 shares during the last quarter. Hedge funds and other institutional investors own 89.62% of the company's stock.

IQVIA Stock Down 0.5 %

Shares of NYSE:IQV traded down $0.94 during mid-day trading on Wednesday, hitting $196.51. 718,908 shares of the company traded hands, compared to its average volume of 1,193,056. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The stock has a market cap of $35.67 billion, a P/E ratio of 25.79, a P/E/G ratio of 2.05 and a beta of 1.49. The stock has a 50-day moving average price of $203.54 and a two-hundred day moving average price of $222.31. IQVIA has a 12-month low of $187.62 and a 12-month high of $261.73.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.